These results support the concept that fuel excess drives obesity and diabetes via hyperinsulinaemia and provide an additional impetus to lower insulin hypersecretion as a potential therapeutic approach for obesity and diabetes. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.